Clinical trial
A Randomized Sham and Placebo-controlled Trial of Adjunctive D-cycloserine in Repetitive Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
NCT05177601 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Sham and Placebo-controlled Trial of Adjunctive D-cycloserine in Repetitive Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
- Lead sponsor
- University of Calgary
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 26, 2021
- Completion date
- October 31, 2025
- Enrollment
- 81 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.